D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RCEL holding history
AVITA Medical, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCEL overviewAll 13F holders of RCELFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −61,971−100.0% | Sold out | Holders |
| Q2 2025 | 61,971 | $327.8K | <0.1% | −9,737−13.6% | Reduced | Holders |
| Q1 2025 | 71,708 | $583.7K | <0.1% | +5,160+7.8% | Added | Holders |
| Q4 2024 | 66,548 | $851.8K | <0.1% | −548−0.8% | Reduced | Holders |
| Q3 2024 | 67,096 | $719.3K | <0.1% | −17,733−20.9% | Reduced | Holders |
| Q2 2024 | 84,829 | $671.8K | <0.1% | +36,700+76.3% | Added | Holders |
| Q1 2024 | 48,129 | $771.5K | <0.1% | −2,427−4.8% | Reduced | Holders |
| Q4 2023 | 50,556 | $693.6K | <0.1% | −3,060−5.7% | Reduced | Holders |
| Q3 2023 | 53,616 | $783.3K | <0.1% | −25,739−32.4% | Reduced | Holders |
| Q2 2023 | 79,355 | $1.35M | <0.1% | −41,344−34.3% | Reduced | Holders |
| Q1 2023 | 120,699 | $1.69M | <0.1% | +90,987+306.2% | Added | Holders |
| Q4 2022 | 29,712 | $196.1K | <0.1% | +9,871+49.8% | Added | Holders |
| Q3 2022 | 19,841 | $105.0K | <0.1% | −317−1.6% | Reduced | Holders |
| Q2 2022 | 20,158 | $96.0K | <0.1% | −9,957−33.1% | Reduced | Holders |
| Q1 2022 | 30,115 | $255.0K | <0.1% | +30,115 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −12,966−100.0% | Sold out | Holders |
| Q3 2021 | 12,966 | $230.0K | <0.1% | +2,969+29.7% | Added | Holders |
| Q2 2021 | 9,997 | $205.0K | <0.1% | +9,997 | New | Holders |